All In MedTech

FDA Clearance Tracker · P210007-S005

Vivistim System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 24, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 24, 2025

Approved

Time to decision

51 days

Received Mar 4, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P210007-S005
Device name
Vivistim System
Applicant location
Austin, TX
Received
Mar 4, 2025
Decided
Apr 24, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P210007

Device type

Device class
Class III

Every decision under product code QPY

FDA's approval statement

As written in FDA's record.

Approval for the Site Change Supplement located at the MN Ops Center, 5155 E. River Rd., Suite 409, Fridley, MN, 55421 for receiving, storage, and shipping of the Vivistim System.

Source documents

Other decisions for Mobia Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.